Pedro Costa

Pedro works in Public Affairs for Johnson & Johnson and had quite the year in 2017. In his role, he has helped create a more favorable climate for companies to invest and create jobs in Puerto Rico. Following the devastating effects of hurricane Maria, Pedro worked to ensure that patients could access critical medications and

Tiffini Brabham, DVM, PhD, DABT

(Pfizer) – Dr. Brabham is a strong advocate for Pfizer’s grassroots and PAC programs. She volunteers for Project 351, an initiative created by Massachusetts Governor Deval Patrick to, “unite diverse 8th grade service Ambassadors from every city and town in the Commonwealth for an inspirational year of community service, leadership development and enrichment.”

Dr. Gersham Dent

In 2020, Dr. Dent was a key voice in discussing the importance of biomarkers for Alzheimer’s disease with members of Congress. She participated in Capitol Hill briefings and attended multiple meetings with legislators to explain the issue. She is a powerful advocate for pioneering innovation and continues to be a trusted advisor and partner to

Victoria Diab

As a specialist in cell therapy, Victoria has played a vital role in engaging policymakers at every level of government including state and federal “fly-ins” hosted by PhRMA. BMS’s Policy, Government Affairs, and Advocacy team is continually impressed by her thoughtful approach to educating and advocating for medical innovation, like CAR T.

Kim Doggett

Kim is an individual who is committed to helping educate policymakers and stakeholders about the important and challenging work of developing new medicines for patients. She participates in several fly-ins and she’s UCB’s leading voice on the importance of diversity in clinical trials and is leading work to advance the company in this area. Her

Jacquelyn Dungey

(Eli Lilly and Company) – Jackie has worked tirelessly to ensure the right voices are heard and the right information is seen by Indiana lawmakers and has encouraged the right level of access for patients and protections that ensure a successful environment for medical innovators in the state, while also finding data that proves how

Marci English

Marci has raised awareness of women’s health needs and research efforts at Astellas to treat them. She has discussed the stigma around talking about menopause and other aspects of women’s health. At the same time, Marci joined researchers from companies around the country to meet with members of Congress and their staff to discuss their

Edio Zampaglione, MD, FACOG

(Bayer) – Dr. Zampaglione is passionate about ensuring all women have access to the information and support they need to take control of their health. He is a champion of Bayer’s support of patient education on family planning through advocacy partnerships.

Joanne Palmisano, MD, FACP

(Boehringer Ingelheim) – Dr. Palmisano is a leading advocate for Boehringer Ingelheim who regularly engages with external stakeholders to support the industry and demonstrate its value to patients and policymakers. Her passion for pediatric therapies has also led her to participate in FDA dialogues on sound policies for pediatric drug development.

Christine Schnackenberg, PhD, FAHA

(GlaxoSmithKline) Dr. Schnackenberg chairs GSK’s Science in the Schools group in Upper Merion, PA. This volunteer group works to provide opportunities for GSK employees to share science in their local communities and inspire future generations of scientists.